ID   AL9A1_RAT               Reviewed;         494 AA.
AC   Q9JLJ3; Q6GMM4;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-OCT-2024, entry version 149.
DE   RecName: Full=4-trimethylaminobutyraldehyde dehydrogenase;
DE            Short=TMABA-DH {ECO:0000303|PubMed:10702312};
DE            Short=TMABADH;
DE            EC=1.2.1.47 {ECO:0000269|PubMed:10702312};
DE   AltName: Full=Aldehyde dehydrogenase family 9 member A1;
DE            EC=1.2.1.3 {ECO:0000269|PubMed:10702312, ECO:0000269|PubMed:1799975};
DE   AltName: Full=Formaldehyde dehydrogenase;
DE            EC=1.2.1.46 {ECO:0000250|UniProtKB:P49189};
DE   AltName: Full=Gamma-aminobutyraldehyde dehydrogenase {ECO:0000303|PubMed:10702312};
DE            EC=1.2.1.19 {ECO:0000269|PubMed:10702312, ECO:0000269|PubMed:1799975};
GN   Name=Aldh9a1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, CATALYTIC
RP   ACTIVITY, PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=10702312; DOI=10.1074/jbc.275.10.7390;
RA   Vaz F.M., Fouchier S.W., Ofman R., Sommer M., Wanders R.J.A.;
RT   "Molecular and biochemical characterization of rat gamma-
RT   trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement
RT   of human aldehyde dehydrogenase 9 in carnitine biosynthesis.";
RL   J. Biol. Chem. 275:7390-7394(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 50-59; 199-223; 275-293 AND 412-426, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=1799975; DOI=10.1016/0305-0491(91)90382-n;
RA   Ambroziak W., Kurys G., Pietruszko R.;
RT   "Aldehyde dehydrogenase (EC 1.2.1.3): comparison of subcellular
RT   localization of the third isozyme that dehydrogenates gamma-
RT   aminobutyraldehyde in rat, guinea pig and human liver.";
RL   Comp. Biochem. Physiol. 100:321-327(1991).
CC   -!- FUNCTION: Converts gamma-trimethylaminobutyraldehyde into gamma-
CC       butyrobetaine with high efficiency (in vitro). Can catalyze the
CC       irreversible oxidation of a broad range of aldehydes to the
CC       corresponding acids in an NAD-dependent reaction, but with low
CC       efficiency. Catalyzes the oxidation of aldehydes arising from biogenic
CC       amines and polyamines. {ECO:0000269|PubMed:10702312,
CC       ECO:0000269|PubMed:1799975}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-(trimethylamino)butanal + H2O + NAD(+) = 4-
CC         (trimethylamino)butanoate + 2 H(+) + NADH; Xref=Rhea:RHEA:17985,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16244,
CC         ChEBI:CHEBI:18020, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.2.1.47;
CC         Evidence={ECO:0000269|PubMed:10702312};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + NAD(+) = a carboxylate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:16185, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:29067, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.3; Evidence={ECO:0000269|PubMed:10702312,
CC         ECO:0000269|PubMed:1799975};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-aminobutanal + H2O + NAD(+) = 4-aminobutanoate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:19105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:58264,
CC         ChEBI:CHEBI:59888; EC=1.2.1.19;
CC         Evidence={ECO:0000269|PubMed:10702312, ECO:0000269|PubMed:1799975};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=formaldehyde + H2O + NAD(+) = formate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:16425, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:16842, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.46;
CC         Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetaldehyde + H2O + NAD(+) = acetate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:25294, ChEBI:CHEBI:15343, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30089, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + imidazole-4-acetaldehyde + NAD(+) = 2 H(+) + imidazole-
CC         4-acetate + NADH; Xref=Rhea:RHEA:31059, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:27398, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:57969;
CC         Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acrolein + H2O + NAD(+) = acrylate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:69084, ChEBI:CHEBI:15368, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:37080, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5-hydroxyindol-3-yl)acetaldehyde + H2O + NAD(+) = (5-
CC         hydroxyindol-3-yl)acetate + 2 H(+) + NADH; Xref=Rhea:RHEA:31215,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:50157,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62622;
CC         Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,4-dihydroxyphenylacetaldehyde + H2O + NAD(+) = 3,4-
CC         dihydroxyphenylacetate + 2 H(+) + NADH; Xref=Rhea:RHEA:69080,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17612,
CC         ChEBI:CHEBI:27978, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + spermine monoaldehyde = 2 H(+) + N-(2-
CC         carboxyethyl)spermidine + NADH; Xref=Rhea:RHEA:69168,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:180903, ChEBI:CHEBI:180913;
CC         Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + propanal = 2 H(+) + NADH + propanoate;
CC         Xref=Rhea:RHEA:67256, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17153, ChEBI:CHEBI:17272, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:1799975};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanal + H2O + NAD(+) = butanoate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:69088, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15743, ChEBI:CHEBI:17968, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + pentanal = 2 H(+) + NADH + pentanoate;
CC         Xref=Rhea:RHEA:69092, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:31011, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:84069; Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hexanal + NAD(+) = 2 H(+) + hexanoate + NADH;
CC         Xref=Rhea:RHEA:67276, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17120, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:88528; Evidence={ECO:0000250|UniProtKB:P49189};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=28 uM for NAD {ECO:0000269|PubMed:10702312};
CC         KM=4 uM for NAD {ECO:0000269|PubMed:1799975};
CC         KM=1630 uM for NADP {ECO:0000269|PubMed:10702312};
CC         KM=1.4 uM for gamma-trimethylaminobutyraldehyde
CC         {ECO:0000269|PubMed:10702312};
CC         KM=24 uM for 4-aminobutyraldehyde {ECO:0000269|PubMed:10702312};
CC         KM=5 uM for 4-aminobutyraldehyde {ECO:0000269|PubMed:1799975};
CC         KM=7 uM for heptanal {ECO:0000269|PubMed:10702312};
CC         KM=6 uM for octanal {ECO:0000269|PubMed:10702312};
CC         KM=7.5 uM for propanal {ECO:0000269|PubMed:1799975};
CC   -!- PATHWAY: Amine and polyamine biosynthesis; carnitine biosynthesis.
CC       {ECO:0000305|PubMed:10702312}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P49189}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10702312}.
CC       Cytoplasm {ECO:0000269|PubMed:1799975}.
CC   -!- TISSUE SPECIFICITY: Detected in lever (at protein level).
CC       {ECO:0000269|PubMed:10702312}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF170918; AAF43598.1; -; mRNA.
DR   EMBL; BC074019; AAH74019.1; -; mRNA.
DR   RefSeq; NP_071609.2; NM_022273.2.
DR   AlphaFoldDB; Q9JLJ3; -.
DR   SMR; Q9JLJ3; -.
DR   BioGRID; 248957; 1.
DR   IntAct; Q9JLJ3; 1.
DR   STRING; 10116.ENSRNOP00000005611; -.
DR   iPTMnet; Q9JLJ3; -.
DR   PhosphoSitePlus; Q9JLJ3; -.
DR   SwissPalm; Q9JLJ3; -.
DR   jPOST; Q9JLJ3; -.
DR   PaxDb; 10116-ENSRNOP00000005611; -.
DR   PeptideAtlas; Q9JLJ3; -.
DR   GeneID; 64040; -.
DR   KEGG; rno:64040; -.
DR   UCSC; RGD:68409; rat.
DR   AGR; RGD:68409; -.
DR   CTD; 223; -.
DR   RGD; 68409; Aldh9a1.
DR   eggNOG; KOG2450; Eukaryota.
DR   InParanoid; Q9JLJ3; -.
DR   OrthoDB; 2291791at2759; -.
DR   PhylomeDB; Q9JLJ3; -.
DR   BioCyc; MetaCyc:MONOMER-14430; -.
DR   BRENDA; 1.2.1.47; 5301.
DR   Reactome; R-RNO-71262; Carnitine synthesis.
DR   SABIO-RK; Q9JLJ3; -.
DR   UniPathway; UPA00118; -.
DR   PRO; PR:Q9JLJ3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0047105; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; IDA:RGD.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD+) activity; IDA:UniProtKB.
DR   GO; GO:0043176; F:amine binding; IDA:RGD.
DR   GO; GO:0019145; F:aminobutyraldehyde dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0018467; F:formaldehyde dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0043878; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0051287; F:NAD binding; IDA:RGD.
DR   GO; GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; ISO:RGD.
DR   GO; GO:0036094; F:small molecule binding; ISO:RGD.
DR   GO; GO:0045329; P:carnitine biosynthetic process; ISO:RGD.
DR   GO; GO:0009437; P:carnitine metabolic process; ISO:RGD.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   CDD; cd07090; ALDH_F9_TMBADH; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   PANTHER; PTHR11699:SF228; 4-TRIMETHYLAMINOBUTYRALDEHYDE DEHYDROGENASE; 1.
DR   PANTHER; PTHR11699; ALDEHYDE DEHYDROGENASE-RELATED; 1.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; ALDH-like; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; NAD; Oxidoreductase;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P49189"
FT   CHAIN           2..494
FT                   /note="4-trimethylaminobutyraldehyde dehydrogenase"
FT                   /id="PRO_0000056489"
FT   ACT_SITE        254
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10007"
FT   ACT_SITE        288
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10008"
FT   BINDING         180
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P56533"
FT   BINDING         232..236
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P56533"
FT   BINDING         391
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P56533"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49189"
FT   MOD_RES         30
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLJ2"
FT   MOD_RES         30
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLJ2"
FT   MOD_RES         59
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLJ2"
FT   MOD_RES         298
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49189"
FT   CONFLICT        493..494
FT                   /note="AF -> PFENQ (in Ref. 2; AAH74019)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   494 AA;  53653 MW;  E417BD52D7DF567C CRC64;
     MSTGTFVVSQ PLNYRGGARV EPVDASGTEK AFEPATGREI ATFKCSGEKE VNLAVENAKA
     AFKIWSKKSG LERCQVLLEA ARIIKERRDE IAIMETINNG KSIFEARLDV DTSWQCLEYY
     AGLAASMAGE HIQLPGGSFG YTRREPLGVC LGIGAWNYPF QIACWKSAPA LACGNAMIFK
     PSPFTPVSAL LLAEIYTKAG APNGLFNVVQ GGAATGQFLC QHRDVAKVSF TGSVPTGMKI
     MEMAAKGIKP ITLELGGKSP LIIFSDCNMK NAVKGALLAN FLTQGQVCCN GTRVFVQKEI
     ADAFTKEVVR QTQRIKIGDP LLEDTRMGPL INAPHLERVL GFVRSAKEQG ATVLCGGEPY
     APEDPKLKHG YYMTPCILTN CTDDMTCVKE EIFGPVMSIL TFETEAEVLE RANDTTFGLA
     AGVFTRDIQR AHRVAAELQA GTCYINNYNV SPVELPFGGY KKSGFGRENG RVTIEYYSQL
     KTVCVEMGDV ESAF
//
